Abacavir Sulfate: CAS Registry Number 188062-50-2

Abacavir sulfate, chemically defined as CAS number 188062-50-2, is a potent HIV medication. It blocks the replication of the human immunodeficiency virus (HIV) by interfering with the viral enzyme reverse transcriptase. This enzyme is crucial in the HIV life cycle, facilitating the virus to insert its genetic material into the host's DNA. Abacavir

read more

Pharmacological Properties of Abacavir Sulfate (188062-50-2)

Abacavir sulfate serves as a nucleoside reverse transcriptase inhibitor utilized in the management of human immunodeficiency virus disease. Its pharmacological properties stem from the potent inhibition of reverse transcriptase, an enzyme crucial for HIV replication. Abacavir sulfate is a metabolite that undergoes transformation to its active form

read more

Premier API Manufacturer & Supplier

In today's rapidly evolving technological landscape, reliable and high-performance APIs are essential for organizations of all sizes. A leading global API manufacturer and supplier delivers a comprehensive range of cutting-edge APIs designed to meet the diverse needs of modern applications. With a strong commitment to quality, innovation, and custo

read more

Pharmacological Properties of Abacavir Sulfate (188062-50-2)

Abacavir sulfate serves as a nucleoside reverse transcriptase inhibitor employed in the treatment of human immunodeficiency virus disease. Its mechanistic properties involve the selective inhibition of reverse transcriptase, an enzyme vital for HIV replication. Abacavir sulfate is a derivative that transits transformation to its active form, carbo

read more

India's Top Nutraceutical API Manufacturer

India has firmly established itself as a global hub for dietary supplement ingredient production, particularly in the realm of Active Pharmaceutical Ingredients (compounds). Numerous Indian firms specialize in the custom synthesis of natural health APIs, serving both the domestic market and exporting globally. These companies boast advanced capabil

read more